In today’s briefing:
- Emcure Pharmaceuticals Pre-IPO – Refiling Updates and Valuations
- India Alcoholic Beverages: Growing in Pints And Quarts. IPO Adds a Valuation Kick
Emcure Pharmaceuticals Pre-IPO – Refiling Updates and Valuations
- Emcure Pharmaceuticals is looking to raise around US$240m in its upcoming India IPO.
- Emcure Pharmaceuticals (EP) is an Indian Pharmaceutical company engaged in the developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
- We have looked at the company’s past performance, in our earlier note. In this note, we talk about the RHP updates and take a quick look at valuations.
India Alcoholic Beverages: Growing in Pints And Quarts. IPO Adds a Valuation Kick
- Allied Blenders & Distillers‘ recent IPO spotlighted India’s alcoholic beverage sector, which bucks global trends with strong volume and value growth.
- India is the third largest alcoholic beverage market globally, and the second largest for spirits. It is projected to grow at a CAGR of more than 10% over the near-term.
- Incumbent players in this highly regulated sector can benefit from strong market moats and evolving growth opportunities if they can effectively navigate the highly regulated business environment.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
